EPISODE · Jan 30, 2026 · 22 MIN
S2 Ep68: From Underdiagnosed to Under Control: Plozasiran and Pharmacists’ Role in FCS
from Pharmacy Focus · host Pharmacy Times
On Chen, MD, and Tahmid Rahman, MD discuss how plozasiran—an RNA-based APOC3-targeting therapy for patients with familial chylomicronemia syndrome with infrequent injections and a favorable safety profile—can transform care when integrated through coordinated multidisciplinary workflows with pharmacists leading patient identification, access, and monitoring.
NOW PLAYING
S2 Ep68: From Underdiagnosed to Under Control: Plozasiran and Pharmacists’ Role in FCS
No transcript for this episode yet
Similar Episodes
No similar episodes found.